170 related articles for article (PubMed ID: 20513102)
1. Absent, unrecognized, and minimal myotonic discharges in myotonic dystrophy type 2.
Young NP; Daube JR; Sorenson EJ; Milone M
Muscle Nerve; 2010 Jun; 41(6):758-62. PubMed ID: 20513102
[TBL] [Abstract][Full Text] [Related]
2. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
[TBL] [Abstract][Full Text] [Related]
3. Myotonic dystrophy type 2 with focal asymmetric muscle weakness and no electrical myotonia.
Milone M; Batish SD; Daube JR
Muscle Nerve; 2009 Mar; 39(3):383-5. PubMed ID: 19208413
[TBL] [Abstract][Full Text] [Related]
4. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
[TBL] [Abstract][Full Text] [Related]
5. Proximal myotonic myopathy: clinical, neuropathologic, and molecular genetic features.
Eisenschenk S; Triggs WJ; Pearl GS; Rojiani AM
Ann Clin Lab Sci; 2001 Apr; 31(2):140-6. PubMed ID: 11337902
[TBL] [Abstract][Full Text] [Related]
6. Clinical, electrophysiologic and pathologic findings in 10 patients with myotonic dystrophy 2.
Dabby R; Sadeh M; Herman O; Leibou L; Kremer E; Mordechai S; Watemberg N; Frand J
Isr Med Assoc J; 2011 Dec; 13(12):745-7. PubMed ID: 22332444
[TBL] [Abstract][Full Text] [Related]
7. The expanding clinical and genetic spectrum of the myotonic dystrophies.
Ricker K
Acta Neurol Belg; 2000 Sep; 100(3):151-5. PubMed ID: 11098287
[TBL] [Abstract][Full Text] [Related]
8. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
[TBL] [Abstract][Full Text] [Related]
9. Does quantitative EMG differ myotonic dystrophy type 2 and type 1?
Szmidt-Salkowska E; Gawel M; Lusakowska A; Nojszewska M; Lipowska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
J Electromyogr Kinesiol; 2014 Oct; 24(5):755-61. PubMed ID: 25052913
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine blocks myotonic runs and reverts abnormal surface electromyogram pattern in patients with myotonic dystrophy type 1.
Chisari C; Licitra R; Pellegrini M; Pellegrino M; Rossi B
Clin Neuropharmacol; 2009; 32(6):330-4. PubMed ID: 19667977
[TBL] [Abstract][Full Text] [Related]
11. Musculoskeletal pain in patients with myotonic dystrophy type 2.
George A; Schneider-Gold C; Zier S; Reiners K; Sommer C
Arch Neurol; 2004 Dec; 61(12):1938-42. PubMed ID: 15596616
[TBL] [Abstract][Full Text] [Related]
12. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2).
Sallinen R; Vihola A; Bachinski LL; Huoponen K; Haapasalo H; Hackman P; Zhang S; Sirito M; Kalimo H; Meola G; Horelli-Kuitunen N; Wessman M; Krahe R; Udd B
Neuromuscul Disord; 2004 Apr; 14(4):274-83. PubMed ID: 15019706
[TBL] [Abstract][Full Text] [Related]
13. Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2.
Merlini L; Sabatelli P; Columbaro M; Bonifazi E; Pisani V; Massa R; Novelli G
Muscle Nerve; 2005 Jun; 31(6):764-7. PubMed ID: 15704146
[TBL] [Abstract][Full Text] [Related]
14. Type 2 myotonic dystrophy can be predicted by the combination of type 2 muscle fiber central nucleation and scattered atrophy.
Bassez G; Chapoy E; Bastuji-Garin S; Radvanyi-Hoffman H; Authier FJ; Pellissier JF; Eymard B; Gherardi RK
J Neuropathol Exp Neurol; 2008 Apr; 67(4):319-25. PubMed ID: 18379436
[TBL] [Abstract][Full Text] [Related]
15. [Electrophysiological features of patients with myotonic dystrophy type 1].
Li M; Wang ZJ; Cui F; Yang F; Chen ZH; Ling L; Huang XS
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(5):345-7. PubMed ID: 23660205
[TBL] [Abstract][Full Text] [Related]
16. Dysphagia is present but mild in myotonic dystrophy type 2.
Tieleman AA; Knuijt S; van Vliet J; de Swart BJ; Ensink R; van Engelen BG
Neuromuscul Disord; 2009 Mar; 19(3):196-8. PubMed ID: 19167224
[TBL] [Abstract][Full Text] [Related]
17. Myotonic dystrophy type 2 and related myotonic disorders.
Meola G; Moxley RT
J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
[TBL] [Abstract][Full Text] [Related]
18. A role for PLCβ1 in myotonic dystrophies type 1 and 2.
Faenza I; Blalock W; Bavelloni A; Schoser B; Fiume R; Pacella S; Piazzi M; D'Angelo A; Cocco L
FASEB J; 2012 Jul; 26(7):3042-8. PubMed ID: 22459146
[TBL] [Abstract][Full Text] [Related]
19. Proximal myopathy and diffuse white matter involvement in myotonic dystrophy type I.
Uluc K; Arsava EM; Erdem S; Tan E
J Neurol; 2002 May; 249(5):629-30. PubMed ID: 12021957
[No Abstract] [Full Text] [Related]
20. [Proximal myotonial myopathy (PROMM): clinical and histology study].
Bassez G; Attarian S; Laforêt P; Azulay JP; Rouche A; Ferrer X; Urtizberea JA; Pellissier JF; Duboc D; Fardeau M; Pouget J; Eymard B
Rev Neurol (Paris); 2001 Feb; 157(2):209-18. PubMed ID: 11283467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
